Moderna Inc. buy UBS Group AG
Start price
21.11.25
/
50%
€20.58
Target price
21.11.26
-
Performance (%)
75.10%
Price
16.01.26
€36.04
Summary
This prediction is currently active. With a performance of 75.10% the BUY prediction by UBS_Group_AG is a big success. This prediction currently runs until 21.11.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Moderna Inc. | 22.277% | 22.277% |
| iShares Core DAX® | 0.191% | 4.892% |
| iShares Nasdaq 100 | -0.614% | 2.901% |
| iShares Nikkei 225® | 0.599% | 7.404% |
| iShares S&P 500 | -0.036% | 3.489% |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna (NASDAQ:MRNA) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for MRNA provided by MarketBeat